A decade-long project that attempted to replicate experiments from several high-profile papers in the field of preclinical cancer biology has found that around half of the experiments couldn’t be replicated on most criteria.
‘This suggests the credibility of published findings in cancer biology are less certain than thought,’ said Brian Nosek, executive director of the Center for Open Science, which oversaw the project. Read more in Chemistry World.